Abstract:The use of nutraceuticals with anti-inflammatory and hypolipidemic activity in the composition of foods for special dietary uses and dietary supplements is one of the effective methods of dietary therapy of alimentary obesity and related diseases. The aim was to study the effect of the combined intake of resveratrol and L-carnitine (RC) on the expression of genes responsible for the metabolism of carbohydrates, fats and inflammatory reactions in the liver and kidneys of rats in normal conditions and with diet-induced obesity. Material and methods. Male Wistar rats received for 63 days a standard balanced diet or a high-fat-high-carbohydrate diet (HFCD) with an excess of total fat (30%) and fructose (20% solution instead of drinking water), or the same diets supplemented with RC in a low (25 mg/kg body weight as resveratrol and 300 mg/kg as L-carnitine) or high (50 and 600 mg/kg body weight, respectively) doses. The expression of genes (Khk, Gck, Pklr, Acaca, Acacb, Fasn, Scd, Srebf1, Mlxipl, Ppara, Pparg, Actb, Gapdh) in liver cells was studied by the method of real-time reverse transcription polymerase chain reaction (RT-PCR). The distribution of tyrosine aminotransferase (TAT), nuclear factor erythroid 2-related factor 2 (NRF-2) and intercellular adhesion molecule type 2 (ICAM-2) in the liver and kidneys was assessed by confocal laser microscopy and immunohistochemistry. Results. Increased expression of Fasn (fatty acid synthase) in rats treated with high-fat high-carbohydrate diet (HFCD) decreased under RC intake. RC consumption caused a decrease in the number of TAT-, NRF-2- and ICAM-2-positive cells in the liver of rats treated with HFCD, but had the opposite effect in the kidneys. The consumption of RC at the low dose by rats fed HFCD caused changes in the expression profiles of the studied marker genes, indicating a possible hypolipidemic effect. However, observed increased expression of lipogenic genes in the liver and elevated level of NRF-2 and ICAM-2 in kidney against the background of consumption of RC with the standard balanced diet cannot be assessed as unambiguously positive. Conclusion. Thus, possible negative effects caused, most likely, by the interaction of nutraceuticals with various mechanisms of action should be taken into account when developing formulations of dietary supplements and foods for special dietary uses for dietary therapy of obesity.

Effects of Quercetin on Expression of Genes of Carbohydrate and Lipid Metabolism Enzymes in the Liver of Rats Receiving High-Fructose Ration

[Effects of quercetin on protective capacity in rats fed a high-fructose diet]

Quercetin Improves Glucose and Lipid Metabolism of Diabetic Rats: Involvement of Akt Signaling and SIRT1

Quercetin Inhibits AMPK/TXNIP Activation and Reduces Inflammatory Lesions to Improve Insulin Signaling Defect in the Hypothalamus of High Fructose-Fed Rats

The effects of quercetin on the expression of SREBP-1c mRNA in high-fat diet-induced NAFLD in mice

Effect of Exercise and Quercetin in Rats with Metabolic Syndrome Induced with Fructose

[Liver gene expression in normal and obese rats received resveratrol and L-carnitine]

COMBINED EFFECTS OF QUERCETIN AND MODULATORS OF REDOX SENSITIVE FACTORS ON THE INDICATORS OF SYSTEMIC INFLAMMATORY RESPONSE, CARBOHYDRATE AND LIPID METABOLISM IN RATS EXPOSED TO INTRAPERITONEAL AND INTRAGINGIVAL ADMINISTRATION OF SALMONELLA TYPHI LIPOPOLY

Quercetin attenuates high fructose feeding-induced atherosclerosis by suppressing inflammation and apoptosis via ROS-regulated PI3K/AKT signaling pathway

Quercetin Preservesβ-Cell Mass and Function in Fructose-Induced Hyperinsulinemia Through Modulating Pancreatic Akt/FoxO1 Activation

The Metabolic Effect of Fructose on Normal Rats in A Mild Dose with Glucose and Saccharose As Control

Quercetin regulates hepatic cholesterol metabolism by promoting cholesterol-to-bile acid conversion and cholesterol efflux in rats

The relationship of fructose consumption with MDA levels in rat liver and its effect on the expression levels of COX-2 and NRF-2 genes

Lipogenic Transcription Factor ChREBP Mediates Fructose-Induced Metabolic Adaptations to Prevent Hepatotoxicity

[Effects of Kaempferol and Quercetin on Cytochrome 450 Activities in Primarily Cultured Rat Hepatocytes].

Fructose Induced Leptin Dysfunction and Improvement by Quercetin and Rutin in Rats

Quercetin decreases fructose drinking in model of fructose-induced insulin resistance. Unexpected uric acid and TBARS lowering effect of methyl cellulose vehicle and fructose combination

Quercetin modulates AMPK/SIRT1/NF-κB signaling to inhibit inflammatory/oxidative stress responses in diabetic high fat diet-induced atherosclerosis in the rat carotid artery.

Evaluation of indicators of carbohydrate and lipid metabolism in rats depending on the type of high-calorie diet

Amelioration of free fatty acid‐induced fatty liver by quercetin‐3‐O‐β‐D‐glucuronide through modulation of peroxisome proliferator‐activated receptor‐alpha/sterol regulatory element‐binding protein‐1c signaling

Quercetin prevents rats from type 1 diabetic liver damage by inhibiting TGF-ꞵ/apelin gene expression